rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Sign in  |  Create a Rediffmail account

Tcg

Subscribe via RSS
Rediff.com  »  News  »   Tcg

  News for Tcg

  • Business

TCG acquires Basell's assets

 A TCG-led consortium headed by Purnendu Chatterjee has acquired the assets of Basell NV, a joint venture between Royal Dutch/Shell Group and BASF.According to sources, the agreement, signed in......

Haldia: TCG alleges foul play

 The legal battle for control of Haldia Petrochemicals Ltd took a new twist on Wednesday when The Chatterjee Group contended before the Company Law Board that 15.5 croreshares of the company were......

TCG to buy clinical trials firm

 TCG Lifesciences, the integrated drug research and development company, is close to acquiring a leading clinical trials company in India.Sources in The Chatterjee Group-promoted company confirmed......

$250-mn drug fund by TCG

 Purnendu Chatterjee-controlled The Chatterjee Group is planning to set up a private equity fund with an initial corpus of $250 million (nearly Rs 1,100 crore) to invest in drug discovery and......

TCG to invest Rs 1,500 cr in 7 cities

 TCG Developments India, a real estate developer promoted by New York-based The Chatterjee Group, will invest Rs 1,500 crore (Rs 15 billion) in seven cities in the country over the next three......

Top Coverage News

World Test Championship 2023

 India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

 Here are news, updates and coverage from violence hit Manipur.

IPL 2023

 Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

 Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

 The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
rediff on the net© 2025 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Feedback - About us | Terms of use - Grievances